title: Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD evanlipson@jhmi.edu.
authors.forename: Evan J
authors.initials: EJ
authors.lastname: Lipson
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD evanlipson@jhmi.edu.
authors.forename: Serena M
authors.initials: SM
authors.lastname: Bagnasco
authors.affiliation: MedStar Georgetown Transplant Institute, Washington, DC.
authors.forename: Jack
authors.initials: J
authors.lastname: Moore
authors.affiliation: Inova Dwight and Martha Schar Cancer Institute, Fairfax, VA.
authors.forename: Sekwon
authors.initials: S
authors.lastname: Jang
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Manisha J
authors.initials: MJ
authors.lastname: Patel
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Andrea A
authors.initials: AA
authors.lastname: Zachary
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Drew M
authors.initials: DM
authors.lastname: Pardoll
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Janis M
authors.initials: JM
authors.lastname: Taube
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Charles G
authors.initials: CG
authors.lastname: Drake
mesh_terms: D064591:Allografts; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006084:Graft Rejection / Q000139:chemically induced*; D006801:Humans; D016867:Immunocompromised Host; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D016030:Kidney Transplantation; D008875:Middle Aged; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary
chemical_list: D000970:Antineoplastic Agents; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor